Symbol="ALDX"
AssetType="Common Stock"
Name="Aldeyra The"
Description="Aldeyra Therapeutics, Inc., a biotechnology company, develops and markets drugs for immune-mediated systemic and eye diseases. The company is headquartered in Lexington, Massachusetts."
CIK="1341235"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="131 HARTWELL AVENUE, SUITE 320, LEXINGTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="483796000"
EBITDA="-62736620"
PERatio="None"
PEGRatio="0"
BookValue="2.334"
DividendPerShare="0"
DividendYield="0"
EPS="-1.11"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.202"
ReturnOnEquityTTM="-0.371"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.11"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="20.38"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.239"
EVToRevenue="-"
EVToEBITDA="-3.075"
Beta="1.118"
num_52WeekHigh="11.97"
num_52WeekLow="4.22"
num_50DayMovingAverage="9.73"
num_200DayMovingAverage="7.43"
SharesOutstanding="58576000"
DividendDate="None"
ExDividendDate="None"
symbol="ALDX"
open="8.02"
high="8.05"
low="7.76"
price="7.83"
volume="877680.00"
latest_trading_day="2023-07-05"
previous_close="7.98"
change="-0.15"
change_percent="-1.8797%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="10"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="90"
Volume_recent_avg="1124280"
Change_recent_avg="0.04"
Delta_recent_avg="0.54"
Variance_recent_avg="0.27"
Change_ratio_recent_avg="0.47"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="90"
Aroon_momentum_negative="10"
image_negative_thumbnail_id_1="106"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0070.jpeg"
image_negative_thumbnail_id_2="1140"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0173.jpeg"
image_neutral_thumbnail_id_1="586"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0013.jpeg"
image_neutral_thumbnail_id_2="546"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_positive_thumbnail_id_1="653"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0055.jpeg"
image_positive_thumbnail_id_2="654"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
